At a glance
ClinicalIndex Comparison RecordN/ACompleted· 329 enrolled
Drug / intervention
quinaprildrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
ASSET (Acupil® Non Interventional Study For Evaluation Of Safety Effectiveness And Tolerability)
In Brief
An observational study evaluating quinapril for Hypertension. Completed, enrolled 329 participants across 18 sites.
Detailed Summary
This is a prospective, non-interventional, non comparative drug study. The efficacy of Quinapril in Asian population has been evaluated, but specifically in Indian patients the data is sparse. Data in a real world setting in a large population of Indian patients would shed more light on the safety, tolerability and effectiveness of Quinapril in the Indian population.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
CountriesIndia
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2009
First PostedJun 2009
Primary CompletionJun 2010
TodayJul 2026
First PostedJun 30, 2009
Enrollment StartJun 1, 2009
Primary CompletionJun 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 17.0 years ago
Interventions
quinaprildrug
per label as non interventional study